Dispersible alcohol/cleaning wipes via topical or wet-end application of acrylamide or vinylamide/amine polymers

1. A wet wipe product comprising a fibrous substrate material, a triggerable binder formulation, and a wetting composition comprising from about 50% to about 100% by weight of an insolubilizing agent in contact with the fibrous substrate material, wherein the triggerable binder formulation is insoluble in the wetting composition and dispersible in disposal water having 500 or greater parts per million of calcium and magnesium ions and is selected from the group consisting of acrylamide polymers and polymer formulations, vinylamide/amine polymers and polymer formulations, and mixtures thereof, and wherein the insolubilizing agent comprises at least one polyol.

2. The wet wipe product of claim 1 wherein the polyol increases in temperature upon exposure to moisture.

3. The wet wipe product of claim 1 wherein the fibrous substrate material has a triggerable binder formulation add-on level of about 0.1 wt. % to about 25 wt. %.

4. The wet wipe product of claim 1 wherein the polyol is a polyhydric alcohol selected from the group consisting of polyalkylene glycol, glycerol, diglycerol, polyglycerol, butylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, hexylene glycol, polyethylene glycol, trimethylene glycol, PEGylated compounds, block copolymers comprising polkalkylene glycol, erythritol, pentaerythritol, sorbitan, glucose, sorbitol, malitol, sucrose, raffinose, trehalose, and mixtures thereof.

5. The wet wipe product of claim 1 wherein the polyol is selected from the group consisting of propylene glycol, polyethylene glycol 300, polyethylene glycol 400, and mixtures thereof.

6. The wet wipe product of claim 1 wherein the triggerable binder formulation is a polymerization product comprising acrylamide or vinylamide/amine monomers and, optionally, at least one monomer selected from the group consisting of acrylic acid, methacrylic acid and their salts, 2-acrylamido-2-methyl-1 propanesulfonic acid and its salts, vinyl sulfonic acid and their salts, and sulfonate monomers.

7. The wet wipe product of claim 1 wherein the triggerable binder formulation is a polymerization product comprising acrylamide or vinylamide/amine monomers and, optionally, at least one monomer selected from the group consisting of [2-(acryloxy)ethyl] trimethyl ammonium chloride, [2-(methacryloxy)ethyl] trimethyl ammonium chloride, (3-acrylamidopropyl) trimethyl ammonium chloride, N,N-diallyldimethyl ammonium chloride, [2-(acryloxy) ethyl] dimethylbenzyl ammonium chloride, [2-(methacryloxy) ethyl] dimethylbenzyl ammonium chloride, [2-(acryloxy)ethyl] dimethyl ammonium chloride, and [2-(methacryloxy)ethyl] dimethyl ammonium chloride.

8. The wet wipe product of claim 1 wherein the wet wipe product has an in-use tensile strength of about 300 g/in. or greater.

9. The wet wipe product of claim 1 wherein the wet wipe product has a disposal strength of about 75 g/in. or less.

10. The wet wipe product of claim 1 wherein the fibrous substrate material is air-laid, wet-laid, or is a coform product.

11. The wet wipe product of claim 1 wherein the wetting composition further comprises at least one additional ingredient selected from the group consisting of anti-microbial agents, hormones, antibiotics, anesthetics, analgesics, immunodilators, contraceptives, odor control additives, microparticulates, microcapsules, preservatives, wetting agents, cleaning agents, surface feel modifiers, fragrances, fragrance, solubilizers, opacifiers, and pH control agents.

12. The wet wipe product of claim 11 wherein the anti-microbial agent is an anti-fungal agent.

13. The wet wipe product of claim 12 wherein the anti-fungal agent is selected from the group consisting of miconazole, econazole, terconazole, saperconazole, itraconazole, butaconazole, clotrimazole, tioconazole, fluconazole and ketoconazole, vericonazole, fenticonazole, sertaconazole, posaconazole, bifonazole, oxiconazole, sulconazole, elubiol, vorconazole, isoconazole, flutrimazole, ternafine, naftifine, amorolfine, butenafine, ciclopirox, griseofulvin, undecyclenic acid, haloprogin, tolnaftate, nystatin, iodine, rilopirox, BAY 108888, purpuromycin, their pharmaceutically acceptable salts, and mixtures thereof.

14. The wet wipe product of claim 11 wherein the anti-microbial agent is an anti-bacterial agent.

15. The wet wipe product of claim 14 wherein the anti-bacterial agent is selected from the group consisting of chlorohexidine gluconate, sodium polystyrene sulfonate, sodium cellulose sulfate, silver particles, silver salts, and mixtures thereof.

16. The wet wipe product of claim 11 wherein the anti-microbial agent is an anti-viral agent.

17. The wet wipe product of claim 16 wherein the anti-viral agent is selected from the group consisting of imiquimod, imiquimod derivatives, podofilox, podophyllin, interferon alpha, reticolos, cidofovir, nonoxynol-9, their pharmaceutically acceptable salts, and mixtures thereof.

18. The wet wipe product of claim 11 wherein the anti-microbial agent is an antiseptic agent.

19. The wet wipe product of claim 18 wherein the antiseptic agent is selected from the group consisting of quaternary ammonium compounds, mercury compounds, and iodine compounds.

20. The wet wipe product of claim 18 wherein the antiseptic agent is selected from the group consisting of benzalkonium chloride, benzethonium chloride, cetrimide, chlorhexidine, hexachlorophene, alcohol, hydrogen peroxide, hexamine hippurate, triclosan, cetylpyridinium chloride, dequalinium chloride, and mixtures thereof.

21. A wet wipe product comprising a fibrous substrate material, a triggerable binder formulation, and a wetting composition comprising from about 50% to about 100% by weight of an insolubilizing agent in contact with the fibrous substrate material, wherein the triggerable binder formulation is insoluble in the wetting composition and dispersible in disposal water having 500 or greater parts per million of calcium and magnesium ions and is selected from the group consisting of acrylamide polymers and polymer formulations, vinyl/amine polymers and polymer formulations, and mixtures thereof, and wherein the insolubilizing agent comprises one or more compounds selected from the group consisting of polyols, lower alcohols, lower glycols, lower ketones, and mixtures thereof, and wherein the wetting composition further comprises an anti-microbial agent.

22. The wet wipe product of claim 21 wherein the polyol increases in temperature upon exposure to moisture.

23. The wet wipe product of claim 21 wherein the fibrous substrate material has a triggerable binder formulation add-on level of about 0.1 wt. % to about 25 wt. %.

24. The wet wipe product of claim 21 wherein the polyol is a polyhydric alcohol selected from the group consisting of polyalkylene glycol, glycerol, diglycerol, polyglycerol, butylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, hexylene glycol, polyethylene glycol, trimethylene glycol, PEGylated compounds, block copolymers comprising polkalkylene glycol, erythritol, pentaerythritol, sorbitan, glucose, sorbitol, malitol, sucrose, raffinose, trehalose, and mixtures thereof.

25. The wet wipe product of claim 21 wherein the polyol is selected from the group consisting of propylene glycol, polyethylene glycol 300, polyethylene glycol 400, and mixtures thereof.

26. The wet wipe product of claim 21 , wherein the lower alcohol, lower glycol, or lower ketone is selected from the group consisting of methyl alcohol, ethyl alcohol, n-propyl alcohol, isopropyl alcohol, n-butyl alcohol, sec-butyl alcohol, tert-butyl alcohol, ethylene glycol, 1,2 propandiol (propylene glycol), 1,3 propane diol, acetone, methylethyl ketone, and mixtures thereof.

27. The wet wipe product of claim 21 wherein the triggerable binder formulation is a polymerization product comprising acrylamide or vinylamide/amine monomers and, optionally, at least one monomer selected from the group comprising acrylic acid, methacrylic acid and their salts, 2-acrylamido-2-methyl-1 propanesulfonic acid and its salts, vinyl sulfonic acid and their salts, and sulfonate monomers.

28. The wet wipe product of claim 21 wherein the triggerable binder formulation is a polymerization product comprising acrylamide or vinylamide/amine monomers and, optionally, at least one monomer selected from the group consisting of [2-(acryloxy)ethyl] trimethyl ammonium chloride, [2-(methacryloxy)ethyl] trimethyl ammonium chloride, (3-acrylamidopropyl) trimethyl ammonium chloride, N,N-diallyldimethyl ammonium chloride, [2-(acryloxy) ethyl] dimethylbenzyl ammonium chloride, [2-(methacryloxy) ethyl] dimethylbenzyl ammonium chloride, [2-(acryloxy)ethyl] dimethyl ammonium chloride, and [2-(methacryloxy)ethyl] dimethyl ammonium chloride.

29. The wet wipe product of claim 21 wherein the wet wipe product has an in-use tensile strength of about 300 g/in. or greater.

30. The wet wipe product of claim 21 wherein the wet wipe product has a disposal strength of about 75 g/in. or less.

31. The wet wipe product of claim 21 wherein the fibrous substrate material is air-laid, wet-laid, or is a coform product.

32. The wet wipe product of claim 21 wherein the anti-microbial agent is an anti-fungal agent.

33. The wet wipe product of claim 32 wherein the anti-fungal agent is selected from the group consisting of miconazole, econazole, terconazole, saperconazole, itraconazole, butaconazole, clotrimazole, tioconazole, fluconazole and ketoconazole, vericonazole, fenticonazole, sertaconazole, posaconazole, bifonazole, oxiconazole, sulconazole, elubiol, vorconazole, isoconazole, flutrimazole, ternafine, naftifine, amorolfine, butenafine, ciclopirox, griseofulvin, undecyclenic acid, haloprogin, tolnaftate, nystatin, iodine, rilopirox, BAY 108888, purpuromycin, their pharmaceutically acceptable salts, and mixtures thereof.

34. The wet wipe product of claim 21 wherein the anti-microbial agent is an anti-bacterial agent.

35. The wet wipe product of claim 34 wherein the anti-bacterial agent is selected from the group consisting of chlorohexidine gluconate, sodium polystyrene sulfonate, sodium cellulose sulfate, silver particles, silver salts, and mixtures thereof.

36. The wet wipe product of claim 21 wherein the anti-microbial agent is an anti-viral agent.

37. The wet wipe product of claim 36 wherein the anti-viral agent is selected from the group consisting of imiquimod, imiquimod derivatives, podofilox, podophyllin, interferon alpha, reticolos, cidofovir, nonoxynol-9, their pharmaceutically acceptable salts, and mixtures thereof.

38. The wet wipe product of claim 21 wherein the anti-microbial agent is an antiseptic agent.

39. The wet wipe product of claim 38 wherein the antiseptic agent is selected from the group consisting of quaternary ammonium compounds, mercury compounds, and iodine compounds.

40. The wet wipe product of claim 38 wherein the antiseptic agent is selected from the group consisting of benzalkonium chloride, benzethonium chloride, cetrimide, chlorhexidine, hexachlorophene, alcohol, hydrogen peroxide, hexamine hippurate, triclosan, cetylpyridinium chloride, dequalinium chloride, and mixtures thereof.